Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic advances in small cell lung cancer.
Worden FP, Kalemkerian GP. Worden FP, et al. Expert Opin Investig Drugs. 2000 Mar;9(3):565-79. doi: 10.1517/13543784.9.3.565. Expert Opin Investig Drugs. 2000. PMID: 11060696 Review.
A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer.
Swiecicki PL, Zhao L, Belile E, Sacco AG, Chepeha DB, Dobrosotskaya I, Spector M, Shuman A, Malloy K, Moyer J, McKean E, McLean S, Wolf GT, Eisbruch A, Prince M, Bradford C, Carey T, Worden FP. Swiecicki PL, et al. Among authors: worden fp. Invest New Drugs. 2015 Dec;33(6):1248-56. doi: 10.1007/s10637-015-0293-8. Epub 2015 Oct 10. Invest New Drugs. 2015. PMID: 26453566 Clinical Trial.
Axitinib in the Treatment of Head and Neck Malignancies.
Swiecicki PL, Spector M, Worden FP. Swiecicki PL, et al. Among authors: worden fp. Curr Clin Pharmacol. 2016;11(2):72-6. doi: 10.2174/1574884711666160518120622. Curr Clin Pharmacol. 2016. PMID: 27188575 Review.
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer.
Swiecicki PL, Bellile E, Sacco AG, Pearson AT, Taylor JM, Jackson TL, Chepeha DB, Spector ME, Shuman A, Malloy K, Moyer J, McKean E, McLean S, Sukari A, Wolf GT, Eisbruch A, Prince M, Bradford C, Carey TE, Wang S, Nör JE, Worden FP. Swiecicki PL, et al. Among authors: worden fp. Invest New Drugs. 2016 Aug;34(4):481-9. doi: 10.1007/s10637-016-0364-5. Epub 2016 May 26. Invest New Drugs. 2016. PMID: 27225873 Free PMC article. Clinical Trial.
A multi-center phase II trial evaluating the efficacy of palbociclib in combination with carboplatin for the treatment of unresectable recurrent or metastatic head and neck squamous cell carcinoma.
Swiecicki PL, Durm G, Bellile E, Bhangale A, Brenner JC, Worden FP. Swiecicki PL, et al. Among authors: worden fp. Invest New Drugs. 2020 Oct;38(5):1550-1558. doi: 10.1007/s10637-020-00898-2. Epub 2020 Jan 24. Invest New Drugs. 2020. PMID: 31981071 Free PMC article. Clinical Trial.
213 results